Education
About Us
Working with TipRanks
Follow Us
ViaDerma (VDRM)
OTHER OTC:VDRM
Total Valuation
ViaDerma has a market cap or net worth of $863.60K. The enterprise value is ―.
Market Cap$863.60K
Enterprise Value―
Share Statistics
ViaDerma has 1,233,713,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,233,713,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ViaDerma’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 41.49%.
Return on Equity (ROE)0.03
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)41.49%
Return on Capital Employed (ROCE)1.50
Revenue Per Employee8.01K
Profits Per Employee54.63
Employee Count75
Asset Turnover0.47
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ViaDerma is 3.05K. ViaDerma’s PEG ratio is 0.31.
PE Ratio3.05K
PS Ratio0.00
PB Ratio-145.25
Price to Fair Value101.36
Price to FCF-41.38
Price to Operating Cash Flow-41.38
PEG Ratio0.31
Income Statement
In the last 12 months, ViaDerma had revenue of 600.50K and earned 4.10K in profits. Earnings per share was 0.00.
Revenue600.50K
Gross Profit600.30K
Operating Income185.27K
Pretax Income4.10K
Net Income4.10K
EBITDA80.71K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -507.18K and capital expenditures 2.00, giving a free cash flow of -507.18K billion.
Operating Cash Flow-507.18K
Free Cash Flow-507.18K
Free Cash Flow per Share>-0.01
Dividends & Yields
ViaDerma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.15
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)37.71
Average Volume (3m)581.10K
Important Dates
ViaDerma upcoming earnings date is Oct 3, 2024, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateOct 3, 2024
Ex-Dividend Date―
Financial Position
ViaDerma as a current ratio of 1.10, with Debt / Equity ratio of -1290.16%
Current Ratio1.10
Quick Ratio1.10
Debt to Market Cap0.03
Net Debt to EBITDA3.87
Interest Coverage Ratio2.42
Taxes
In the past 12 months, ViaDerma has paid 4.00 in taxes.
Income Tax4.00
Effective Tax Rate<0.01
Enterprise Valuation
ViaDerma EV to EBITDA ratio is 158.53, with an EV/FCF ratio of 73.11K.
EV to Sales21.31
EV to EBITDA158.53
EV to Free Cash Flow73.11K
EV to Operating Cash Flow73.11K
Balance Sheet
ViaDerma has $1.49M in cash and marketable securities with $1.86M in debt, giving a net cash position of $371.61K billion.
Cash & Marketable Securities$1.49M
Total Debt$1.86M
Net Cash$371.61K
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 99.97%, with operating margin of 30.85%, and net profit margin of 0.68%.
Gross Margin99.97%
Operating Margin30.85%
Pretax Margin0.68%
Net Profit Margin0.68%
EBITDA Margin13.44%
EBIT Margin13.41%
Analyst Forecast
The average price target for ViaDerma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.52%
EPS Growth Forecast-100.00%